ChartRow logo
ChartRow
Stocks and ETFs
Sign in
AMGN
Amgen Inc.Stock · Healthcare
$374.15+$12.82 (+3.55%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

How Amgen makes money

Fiscal year

How does Amgen make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year. Straight from SEC filings.

Amgen Inc. · FY2025 · year ended 2025-12-31
Revenue$36.8BGross profit$24.7B · 67%Cost of revenue$12.0B · 33%Operating income$9.1B · 25%Operating expenses$15.6B · 43%R&D$7.3B · 20%SG&A$7.0B · 19%Other opex$1.3B · 4%Net income$7.7B · 21%Income tax$1.3B · 3%Other Products$7.3B · 20%Prolia$4.4B · 12%Repatha$3.0B · 8%Otezla$2.3B · 6%Enbrel$2.2B · 6%EVENITY$2.1B · 6%Xgeva$2.1B · 6%TEPEZZA$1.9B · 5%Product & Service Other$1.6B · 4%BLINCYTO$1.6B · 4%Nplate$1.5B · 4%TEZSPIRE$1.5B · 4%KYPROLIS$1.4B · 4%Aranesp$1.4B · 4%KRYSTEXXA$1.3B · 4%Vectibix$1.2B · 3%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.